Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Ascletis Becomes Another Contender For ‘Best-In-Class’ Oral GLP-1
Feb 20 2025
•
By
Andrew McConaghie
Survodutide Achieved Up To 18.7% Weight Loss At 46 Weeks • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Start-Ups & SMEs
More from Therapy Areas